An assessment of biologically-based optimization (BORT) in the IMRT era.

The purpose of this study was to investigate the role of biological-based IMRT (BORT) in treatment planning development; more specifically, to assess the possible advantages of BORT over the classic 3-dimensional conformal radiation therapy (3DRT) and dose-based IMRT based on quantitative and qualitative indices. Three clinical cases are presented to evaluate the differences of BORT, IMRT, and 3DRT. 3DRT, IMRT, and BORT plans were generated for each case using a commercially available treatment planning system (Pinnacle by Philips). The plans were compared by evaluating biological endpoints such as tumor control probability (TCP), normal tissue control probability (NTCP), and uncomplicated tumor control probability (P+), as well as isodose line distribution, dose-volume histograms (DVHs), and dose uniformity. In all cases of this study, BORT yielded improved isodose coverage and P+. Our preliminary results suggest that BORT could play an important role in treatment planning optimization, especially as biological models and predictive assays become more accurate. Further case studies are needed to establish a definitive role for this type of optimization.

[1]  A. Brahme,et al.  Optimized radiation therapy based on radiobiological objectives. , 1999, Seminars in radiation oncology.

[2]  A Brahme,et al.  Individualizing cancer treatment: biological optimization models in treatment planning and delivery. , 2001, International journal of radiation oncology, biology, physics.

[3]  A Brahme,et al.  Tumour and normal tissue responses to fractionated non-uniform dose delivery. , 1992, International journal of radiation biology.

[4]  C Kappas,et al.  Optimization of the dose level for a given treatment plan to maximize the complication-free tumor cure. , 1999, Acta oncologica.

[5]  J C Horiot,et al.  The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  A Brahme,et al.  Optimization of uncomplicated control for head and neck tumors. , 1990, International journal of radiation oncology, biology, physics.

[7]  A Brahme,et al.  Biologically effective uniform dose (D) for specification, report and comparison of dose response relations and treatment plans. , 2001, Physics in medicine and biology.

[8]  A Brahme,et al.  Dosimetric precision requirements in radiation therapy. , 1984, Acta radiologica. Oncology.

[9]  C. West,et al.  Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. , 1995, The British journal of radiology.